Profile avatar
bealoquebea.bsky.social
Gastroenterologist #IBD specialist Help others grow their abilities and celebreate life. 🆓 IBD education https://ibd-eii.com/ @WHO.fides member
85 posts 912 followers 240 following
Prolific Poster
Conversation Starter

In the 📕#RedJournal: Diagnosis and Management of Clostridioides difficile in Inflammatory Bowel Disease Byron P. Vaughn, MD, MS; Alexander Khoruts, MD & Monika Fischer, MD, MSc, FACG 👉 bit.ly/3EYVbEp

This is wild. Tasting things virtually www.science.org/doi/10.1126/... Front page @nytimes.com www.nytimes.com/2025/02/28/s...

3 points of progress vs pancreatic cancer! 1. Neoantigen vaccines www.nature.com/articles/s41... 2. KRAS drugs www.wsj.com/health/healt... 3. Early diagnosis www.science.org/doi/10.1126/...

#WeekendRead! #WeAreWhatWeEat! Lesbats, Garaude &co show @nature.com that macrophages recycle phagocytosed bacteria to fuel their metabolism but that dead, compared to live, bacteria still feed macrophages but reduce the induction of ROS & the secretion of IL1b! www.nature.com/articles/s41...

🔎Strictures in Crohn's disease can be challenging to manage I've put together a summary on different approaches and an infographic on strictureplasties Patients want to know about this, so I hope this can serve as an useful resource 🆕www.ibd-eii.com/ibdcheatsheet #IBD

🔎Strictures in Crohn's disease can be challenging to manage I've put together a summary on different approaches and an infographic on strictureplasties Patients want to know about this, so I hope this can serve as an useful resource 🆕www.ibd-eii.com/ibdcheatsheet #IBD

Wrapping up February with the latest updates on www.ibd-eii.com ! This month's newsletter, coming this evening, includes new triss and #IBD cheatsheets! Some interesting research, like this one on hemorrhoid therapy in IBD (📷). Stay tuned!

As a UEG Young Talent Group member, you can have the chance to shape educational programmes and support the next generation of specialists! Learn more and apply by March 13: https://bit.ly/3p0zyJo 🌟 #myUEGcommunity #weareUEG @bealoquebea.bsky.social

Paradigm Shift in Inflammatory Bowel Disease Management: Precision Medicine, Artificial Intelligence, and Emerging Therapies Our latest publication www.mdpi.com/2077-0383/14...

It was a pleasure to present our collaboration with PREDICT at #ECCO2025 last week. We demonstrate subgroups of IBD patients can be characterised by distinct FC and CRP profiles, validated independently in 🇩🇰. The preprint is available here: doi.org/10.1101/2024...

Adolescents after laparoscopic sleeve gastrectomy (N=12) ⬆️ microbial diversity Enrichment of Streptococcus&Actinomyces (oral-bacteria) ‼️⬆️ fecal calprotectin 6/8 patients(p=0.0016),5months post-op ?impact of bariatric surgery&IBD risk @gamonasterioo.bsky.social www.tandfonline.com/doi/full/10....

New personal view article How can the gut #microbiome be targeted to fight multidrug-resistant organisms? www.thelancet.com/journals/lan... #IDSky #ClinMicro #AMR #OpenAccess #OA

REScUE trial of patients with CD losing response to UST All patients received IV reinduction and then q4w SC vs q8w SC ❗️Primary outcome: SF clinical remission: PRO2 & FCP <250 & no steroids for 90 days before w48 ‼️Less than 20% met primary outcome #ECCO2025

Clusters of antibiotic use patterns after the first episode of pouchitis 4⃣ groups: rare intermittent > intermittent > chronic antibiotic-responsive > chronic antibiotic dependent antiTNF prior IPAA & antibióticos in the 12 months prior pouch formation associated with chronic pouchitis #ECCO2025

Phase 1b study of SOR102, orally delivered bispecific anti-TNF/anti-IL-23 domain antibody in mild to severe UC !! Phase 1b very small N so caution with interpretation It surprised me the fact that it includes also patients with mild #UC? giving a double acting #IBD #ECCO2025

Very nice tandem of @Iris_Dotan and Revital Barkan about how far should we pursue our targets to help patients live a normal life? ✅How fast should we act? FASTER & FURTHER ✅Stratify patients better ✅Multidisciplinary approach 🌍Address community gaps

Well, that never worked. Even the Takeda folks knew it was a dry well. More is not always better. If Vedo is not working, move on in #IBD. #ECCO2025 @bealoquebea.bsky.social

Duvakitug (TEV-48574) Anti-TL1A- RELIEVE UCCD trial Results from a Phase 2b trial #IBD #CD #ECCO2025

🚀 Are you passionate about shaping the future of gastroenterology? Join UEG’s Young Talent Group! Learn more and apply by March 13: https://bit.ly/3p0zyJo #myUEGcommunity #weareUEG

Over 400 million people globally are affected by alcohol use disorder. In @lancetgastrohep.bsky.social, a new Review explores the current management and treatment options for alcohol use disorder from a gastroenterology and hepatology-focused perspective: tinyurl.com/43fxj63f

Identifying patients with chronic hepatitis B who are a priority for antiviral therapy APRI >0·5 or FibroScan >7·0 kPa identifies most adults with significant fibrosis (≥F2) APRI >1·0 or FibroScan >12·5 kPa to identifies most adults with cirrhosis (F4) #HepSky #LiverSky #MedSky

The race to explain why more young adults are getting cancer #GastroSky #OncSky #MedSky

None better than @ibdseb.bsky.social to talk about underrepresented populations in #IBD research #ECCO2025 Difficult to choose the best slides, thanks Seb

School for Clinical trialist #ECCO2025 Starting by @J_Kirchgesner introducing how to set your path from the early days #ibd

How to organize an IBDD research Unit from Scratch by @SeverineVermei1 #ECC02025 #ibd

How to create a global consortium by @DrAilsaHart at #ECCO2025 Huge expertise with the perianal disease consortium Great to see how this has progressed from the first idea #ibd

Outstanding review by Nuru Noor revisiting the design of clinical trials #ECCO2025 #ibd

Getting your real-time heart rhythm monitored for 10 days now requires an ECG technician to review and notify your doctor of a critical arrhythmia. A new study showed A.I. did better than technicians (98.6% vs 80.3%) for identifying these abnormalities nature.com/articles/s41...

Mesalazine for periodontitis via regulation of periodontal microbiota and inhibiting Porphyromonas gingivalis I know @gamonasterioo.bsky.social will enjoy this read pmc.ncbi.nlm.nih.gov/articles/PMC...

Two years ago,I had a crazy idea I want to say thank you to everyone who saw a young girl believing in herself and chose to believe in her too 📈390k visits & more than 39k users.Reminder that science knows NO borders & we are all connected by the same passion & mission:to help others #ibd

Management of Necrotizing Acute ⚡️ Pancreatits in the modern era 🇺🇸 25K acute pancreatitis (20% necrotizing) 🪡 14% underwent procedural intervention 🏥 Low volume > open necrosectomy vs. MI / endoscopy 👍 High volume > improved survival / resources journals.lww.com/annalsofsurg... #SurgSky #HPBSky

FMT did not result in an improvement in lower gastrointestinal tract symptoms in patients with systemic sclerosis @thelancet.bsky.social #FMT www.thelancet.com/journals/lan...

Fantastic meeting of the Quality of Care committee of the UEG in Vienna 🤩

#WorldCancerDay is here! 🌍 Digestive cancers have increased by 26% between 2000-2019 in Europe, now causing 1/3 of cancer-related deaths. We need greater investment in prevention, treatment, and research funding to turn the tide. 💚🔬 Learn more ➡️ https://bit.ly/4g6TmSJ. #EUNewsline

Meeting Brigida Barbeiro, someone I have admired for years for her work in #IBD thanks to @myueg.bsky.social

Who did this to @bealoquebea.bsky.social timeline?! ibd-eii.com/timeline/